Mostrar el registro sencillo del ítem

Chatting with ChatGPT to learn about safety of COVID-19 vaccines-A perspective

dc.contributor.authorSalas Ellacuriaga, Antonio*
dc.contributor.authorRivero Calle, Irene*
dc.contributor.authorMartinón Torres, Federico *
dc.date.accessioned2025-09-08T11:51:16Z
dc.date.available2025-09-08T11:51:16Z
dc.date.issued2023
dc.identifier.citationSalas A, Rivero-Calle I, Martinón-Torres F. Chatting with ChatGPT to learn about safety of COVID-19 vaccines-A perspective. Vol. 19, Human Vaccines and Immunotherapeutics. Taylor and Francis Ltd.; 2023.
dc.identifier.issn2164-554X
dc.identifier.otherhttps://portalcientifico.sergas.gal//documentos/64fffbd3ab53484a600239d5
dc.identifier.urihttp://hdl.handle.net/20.500.11940/21210
dc.description.abstractVaccine hesitancy is among the top 10 threats to global health, according to the World Health Organization (WHO). In this exploration, we delve into ChatGPT capacity to generate opinions on vaccine hesitancy by interrogating this AI chatbot for the 50 most prevalent counterfait messages, false and true contraindications, and myths circulating on the internet regarding vaccine safety. Our results indicate that, while the present version of ChatGPT's default responses may be incomplete, they are generally satisfactory. Although ChatGPT cannot substitute an expert or the scientific evidence itself, this form of AI has the potential to guide users toward information that aligns well with scientific evidence.
dc.description.sponsorshipWe are in debt with Siddhartha Sankar Datta for his very kind contribution to the manuscript as a WHO expert evaluator.
dc.languageeng
dc.rightsAttribution-NonCommercial 4.0 International (CC BY-NC 4.0)*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.subject.meshHumans *
dc.subject.meshCOVID-19 Vaccines *
dc.subject.meshCOVID-19 *
dc.subject.meshInternet *
dc.subject.meshSoftware *
dc.subject.meshVaccination Hesitancy *
dc.titleChatting with ChatGPT to learn about safety of COVID-19 vaccines-A perspective
dc.typeArtigo
dc.authorsophosSalas, A.; Rivero-Calle, I.; Martinón-Torres, F.
dc.identifier.doi10.1080/21645515.2023.2235200
dc.identifier.sophos64fffbd3ab53484a600239d5
dc.issue.number2
dc.journal.titleHuman Vaccines and Immunotherapeutics*
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Santiago::Pediatría
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario de Santiago::Pediatría
dc.relation.projectIDWe are in debt with Siddhartha Sankar Datta for his very kind contribution to the manuscript as a WHO expert evaluator.
dc.relation.publisherversionhttps://doi.org/10.1080/21645515.2023.2235200
dc.rights.accessRightsopenAccess*
dc.subject.keywordAS Santiago
dc.subject.keywordIDIS
dc.subject.keywordAS Santiago
dc.subject.keywordCHUS
dc.subject.keywordAS Santiago
dc.subject.keywordCHUS
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)
dc.typesophosArtículo Original
dc.volume.number19


Ficheros en el ítem

Descargar/
Nombre:
563.pdf
Tamaño:
1.136Mb
Formato:
PDF
Descripción:
Salas A, Rivero-Calle I, Martinón-Torres F. Chatting with ChatGPT to learn about ...

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)